ArticleFrontiers in immunology2021

EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8

Christopher J Stairiker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.